Ess Life Sciences India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 34.23%
- Profit Growth 70.66%
- Ebitda 58.84%
- Net Worth 51.97%
- Total Assets 49.08%
About Ess Life Sciences India
Ess Life Sciences India Private Limited (ELSIPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 November 2018 (Six years and three months 16 days old ). Its registered office is in South Delhi, Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Swati Goswami and Dwarka Nath serve as directors at the Company.
Company Details
- Location
South Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999DL2018PTC341681
- Company No.
341681
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Nov 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Ess Life Sciences India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swati Goswami  | Director | 09-Nov-2018 | Current |
| Dwarka Nath | Director | 04-Sep-2021 | Current |
Financial Performance of Ess Life Sciences India.
Ess Life Sciences India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.23% increase. The company also saw a substantial improvement in profitability, with a 70.66% increase in profit. The company's net worth Soared by an impressive increase of 51.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ess Life Sciences India?
Unlock access to Ess Life Sciences India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Raik Solutions India Private LimitedSwati Goswami and Dwarka Nath are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ess Life Sciences India?
Ess Life Sciences India has a workforce of 145 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ess Life Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ess Life Sciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
